← Back to Patent Explorer
US4356181A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-allergic mono salt of 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid

Assignee: Fisons Ltd
•
Filing: 1981-03-26
•
Granted: 1982-10-26
•
Expires: 2001-03-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is described the mono salt of 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid with a strongly basic cation. There is also described an aqueous solution of 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid the solution being at a pH of from 4 to 8. The salts and solutions are useful as pharmaceuticals, e.g. in the treatment of allergies.

Inventors

  • 👤 David W. Payling
  • 👤 John L. Suschitzky

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 00:57
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/48; A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61K9/00; A61K9/0012; A61K9/007; A61K9/0073; A61K9/0075; A61K9/008; A61P; A61P11/00; A61P37/00; A61P37/08; A61Q; A61Q11/00; C07D491/00; C07D491/02; C07D491/04

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 13 words
A mono salt of 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid with a strongly basic pharmaceutically acceptable cation.
Claim 2
Dependent Claim 13 words
A mono salt of 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid with a strongly basic pharmaceutically acceptable cation.
Claim 3
Dependent Claim 14 words
A salt according to claim 1, wherein the cation is an alkali metal cation.
Claim 4
Dependent Claim 12 words
A salt according to claim 2 which is 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, monosodium salt.
Claim 5
Dependent Claim 21 words
An aqueous solution of a mono salt according to claim 1, the solution having a pH of from 4 to 8.
Claim 6
Dependent Claim 13 words
A solution according to claim 4 having a pH of 4.5 to 7.
Claim 7
Dependent Claim 13 words
A solution according to claim 5 having a pH of 5.0 to 6.5.
Claim 8
Dependent Claim 11 words
A solution according to claim 4 which is a buffered solution.
Claim 9
Dependent Claim 38 words
A pharmaceutical composition useful for treatment of reversible airway obstruction or for prevention of the excretion of excess mucous comprising an effective amount of a salt according to claim 1 and a pharmaceutically acceptable excipient, diluent or carrier.
Claim 10
Dependent Claim 14 words
A composition according to claim 8 in a form suitable for administration by inhalation.
Claim 11
Dependent Claim 23 words
A composition according to claim 8 comprising from 0.001 to 200 mg of a salt according to claim 1 in unit dosage form.
Claim 12
Dependent Claim 42 words
A method of treatment of reversible airway obstruction or of prevention of the excretion of excess mucous which comprises administering an effective amount of a salt according to claim 1 to an individual suffering or liable to suffer from such a condition.
Claim 13
Dependent Claim 42 words
A method of treatment of reversible airway obstruction or of prevention of the excretion of excess mucous which comprises administering an effective amount of a solution according to claim 4 to an individual suffering or liable to suffer from such a condition.

References Cited (Backward Citations)

GB2022078A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-10-25 1986-04-26 1986-10-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-10-25 1990-04-26 1990-10-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-10-25 1994-04-26 1994-10-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag